Ukrainian company wishes to act as a manufacturer of veterinary products under an outsourcing agreement

CommercialUkrajinaBOUA20210923001
Offers
Summary: 
The Ukrainian company is a manufacturer of veterinary feed additives and a wide range of veterinary drugs for poultry, cattle, horses and pets. The company is ready to act as a producer for partners who are interested in the production of veterinary products under a manufacturing agreement or outsourcing agreement.
Description: 
The Ukrainian company develops and manufactures high-quality and innovative veterinary feed additives, as well as a wide range of veterinary drugs for poultry, cattle, horses and pets. The company produces a wide range of drugs, feeds, additives, etc. The company also has a new modern plant for the production of sterile drugs for injections, and non-sterile forms of drugs. The powerful equipment of the company allows it to manufacture veterinary drugs and produce all kinds of medicinal and cosmetic forms: tablets, granules, suspensions, water and oil solutions, eye drops, injectable drugs, sprays, gels, ointments, pet shampoos, and balms. The company meets the EU requirements for the right to produce sterile products. Also, all manufactured products pass several laboratory tests for quality and safety for animals. The company is actively growing and developing in order to use the production as efficiently as possible, the company is looking for partners for which it will act as a manufacturer of veterinary products, such as drugs, feeds, additives, etc.,under the manufacturing or outsourcing agreement.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought: 
The company is looking for partners involved in the distribution and production of veterinary medicines who want a Ukrainian company to produce their products under a production or outsourcing agreement. The company wishes to act as a manufacturer, for the customer company, and produce, according to the technical requirements, products such as drugs, feeds, additives, etc. within the framework of a manufacturing or outsoarcing agreement. Priority: production of sterile dosage forms for injection for sale and for the production of these forms under the TM partner
External code: 
BOUA20210923001